Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e

An isolated nucleic acid molecule selected from the group consisting of:

• a) a nucleic acid molecule having a nucleotide sequence which is at least 90% identical to the nucleotide sequence set forth in FIGS. 1A-C or in FIGS. 2A-C, or a complement thereof;
• b) a nucleic acid molecule comprising at least 15 nucleotide residues and having a nucleotide sequence identical to at least 15 consecutive nucleotide residues of the nucleic acid sequence set forth in FIGS. 1A-C or in FIGS. 2A-C, or a complement thereof;
• c) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence set forth in FIGS. 1A-C or in FIGS. 2A-C;
• d) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence set forth in FIGS. 1A-C or in FIGS. 2A-C, wherein the fragment comprises at least 10 consecutive amino acid residues of the amino acid sequence set forth in FIGS. 1A-C or in FIGS. 2A-C;
• e) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence set forth in FIGS. 1A-C or in FIGS. 2A-C, wherein the fragment comprises consecutive amino acid residues corresponding to at least half of the full length of the amino acid sequence set forth in FIGS. 1A-C or in FIGS. 2A-C;
• and
• f) a nucleic acid molecule which encodes a naturally occurring allelic variant of a polypeptide comprising the amino acid sequence set forth in FIGS. 1A-C or in FIGS. 2A-C, wherein the nucleic acid molecule hybridizes with a nucleic acid molecule consisting of the nucleotide sequence set forth in FIGS. 1A-C or in FIGS. 2A-C, or a complement thereof under stringent conditions.